Skip to content

Effect of Nocturnal Parenteral Nutrition on Bone Turnover and Energy Metabolism

The Effect of Parenteral Nutrition During Nighttime Versus Daytime on Bone Turnover and Energy Metabolism in Intestinal Failure Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05868785
Acronym
NutriSync
Enrollment
20
Registered
2023-05-22
Start date
2023-07-13
Completion date
2025-11-30
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Intestinal Failure, Osteoporosis

Keywords

Parenteral Nutrition, Intestinal Failure, Circadian misalignment

Brief summary

This clinical trial will study the effect of daytime versus nighttime parenteral nutrition on bone turnover, glucose variability, nitrogen balance, sleep and wake rhythm and peripheral clock gene expression in patients with chronic intestinal failure.

Detailed description

Objective: This randomized crossover pilot study aims to determine the effect of nocturnal versus daytime cyclic infusion of parenteral nutrition in adult patients with chronic intestinal failure on bone turnover, glucose metabolism, nitrogen balance, sleep and wake rhythm and clock genes expression. This study will include 20 adult patients with chronic intestinal failure. Patients will receive nocturnal parenteral nutrition for 2 weeks (period A) and will switch to daytime parenteral nutrition (period B) for 2 weeks (random assignment). During both study periods glucose variability and sleep / wake rhythm will be measured. After both study periods, patients will be admitted to the metabolic unit for 24 hours to measure bone turnover markers, nitrogen balance, glucoregulatory hormones, energy expenditure and substrate oxidation rates and clock gene expression in leukocytes.

Interventions

DIETARY_SUPPLEMENTParenteral nutrition

Parenteral nutrition will be administered starting at 8 pm

Sponsors

Netherlands Organisation for Scientific Research
CollaboratorOTHER_GOV
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Randomized crossover pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Home parenteral nutrition for at least 5 nights a week * On home parenteral nutrition for more than 1 year * No major changes in parenteral nutrition for 3 months prior to inclusion

Exclusion criteria

* Parenteral infusion for more than 16 h a day * Use of bone modifying drugs in the last 2 years * Bone fractures in the past year * Renal insufficiency (eGFR \< 60 ml/min) * HbA1c ≥48 mmol/ml * Use of corticosteroids * Shift work * Performing intensive exercise (\> 2 hours a day and \> 3 times a week)

Design outcomes

Primary

MeasureTime frameDescription
Changes in glucose variability2 weeks versus 2 weeksChanges in glucose variability measured by a continuous glucose monitor
Differences in bone turnover marker Procollagen 1 Intact N-Terminal PropeptideStudy day 1 versus study day 2Differences in the bone turnover marker Procollagen 1 Intact N-Terminal Propeptide (ug/L)
Differences in bone turnover marker carboxy-terminal collagen crosslinksStudy day 1 versus study day 2Differences in bone turnover marker carboxy-terminal collagen crosslinks (ng/L)

Secondary

MeasureTime frameDescription
Changes in nitrogen balanceStudy day 1 versus study day 2Changes in nitrogen balance by comparing output (feces/urine) versus intake (oral/enteral/parenteral)
Changes in sleep/wake rhythm2 weeks versus 2 weeksChanges in sleep/wake rhythm measured by an actigraph
Changes in sleep quality2 weeks versus 2 weeksChanges in sleep quality, measured by Visual Analogue Scale (VAS) score (scale 1-10, higher scores mean better outcome)
Changes in energy expenditureStudy day 1 versus study day 2Changes in energy expenditure assessed by indirect calorimetry (kcal/24h)
Changes in substrate oxidation ratesStudy day 1 versus study day 2Changes in substrate oxidation rates assessed by indirect calorimetry (percent)
Changes in clock gene expressionStudy day 1 versus study day 2Changes in clock gene expression in leukocytes (if feasible; pilot)
Changes in plasma insulinStudy day 1 versus study day 2insulin (pmol/L)
Changes in plasma glucagonStudy day 1 versus study day 2glucagon (ng/L)

Other

MeasureTime frameDescription
Changes in body temperatureStudy day 1 versus study day 2Changes in body temperature measured by i-buttons (Celsius)

Countries

Netherlands

Contacts

Primary ContactM.J.M. Serlie, professor
m.j.m.serlie@amsterdamumc.nl+31205669111
Backup ContactP.H.L.T. Bisschop, professor
p.h.bissschop@amsterdamumc.nl+31205669111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026